Mario Rossi

Mario Rossi

National Institutes of Health - Bethesda / United States
Others
AD Scientific Index ID: 4386674
person_outline Mario Rossi's MOST POPULAR ARTICLES
1-) Heterodimerization of dopamine receptors: new insights into functional and therapeutic significanceR Maggio, G Aloisi, E Silvano, M Rossi, MJ MillanParkinsonism & related disorders 15, S2-S7, 2009892009
2-) β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditionsL Zhu, J Almaça, PK Dadi, H Hong, W Sakamoto, M Rossi, RJ Lee, ...Nature communications 8 (1), 14295, 2017882017
3-) Muscarinic receptors as model targets and antitargets for structure-based ligand discoveryAC Kruse, DR Weiss, M Rossi, J Hu, K Hu, K Eitel, P Gmeiner, J Wess, ...Molecular pharmacology 84 (4), 528-540, 2013692013
4-) The tetrahydroisoquinoline derivative SB269, 652 is an allosteric antagonist at dopamine D3 and D2 receptorsE Silvano, MJ Millan, CM la Cour, Y Han, L Duan, SA Griffin, RR Luedtke, ...Molecular pharmacology 78 (5), 925-934, 2010662010
5-) The first negative allosteric modulator for dopamine D2 and D3 receptors, SB269652 may lead to a new generation of antipsychotic drugsM Rossi, I Fasciani, F Marampon, R Maggio, M ScarselliMolecular pharmacology 91 (6), 586-594, 2017482017